Genetic testing of embryos for repeat IVF failure
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study tests embryos before pregnancy using genetic screening to look for extra or missing chromosomes, in people who have had repeated IVF embryo transfers without success. It may help reduce the chance of transferring embryos that are unlikely to result in a healthy pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman who has had repeat IVF embryo transfer failure—at least 4 good-quality embryos transferred across at least 3 fresh or frozen cycles
- Your body mass index (BMI) is below 35
- Your uterine cavity exam (hysteroscopy) is normal
- You have not previously been told you have a very thin uterine lining (under 6 mm) in prior cycles
- You do not have certain conditions, such as moderate-to-severe endometriosis, premature ovarian failure, or abnormal chromosome results; and you are not using donor eggs or donor embryos
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether checking the timing of the uterine lining (endometrium) before transferring an embryo can help women who have had multiple failed embryo transfers. It aims to improve the chance of a successful pregnancy for women under 35 with no known cause for their infertility.
This study looks at immune-related blood patterns and other measurements to better understand why some women have repeated pregnancy loss or repeated IVF implantation failure. If you qualify, your answers and test results may help researchers identify biomarkers that could guide future care.
This trial is for women aged 35–40 doing IVF. It compares genetic testing of embryos before transfer to standard care, to see if it improves pregnancy success.
This study looks at using embryo genetic testing before pregnancy in IVF for women aged 35 to 40. It may help by identifying which embryos are more likely to lead to a healthy pregnancy, though you would still be screened to confirm you fit the criteria.
This study tests an upgraded method to screen embryos for genetic abnormalities before implantation during fertility treatment. It may help couples with age-related fertility concerns, repeated implantation failures, recurrent miscarriages, or male factor infertility achieve successful pregnancy.
This study looks at embryo health using a DNA test called PGT-A for couples having IVF. It may help researchers better understand what the test can and cannot tell about which embryos are healthiest.
Hear when a new Recurrent Implantation Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.